Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Parker & Waichman, LLP Attorneys at Law NeutroSpec Information Guide The Case Against NeutroSpec: NeutroSpec is a radiopharmaceutical imaging agent approved in the United States for the diagnosis of equivocal appendicitis has been removed from the market. The manufacturer, Palatin Technologies Inc. and marketing partner, Mallinckrodt, removed NeutroSpec after the FDA said the drug can cause severe, lifethreatening reactions in some people. NeutroSpec is injected into a patient's bloodstream to help doctors diagnose ailments, Manufacturer: Palatin Technologies Date Approved: September 2004 Status: Removed 12/19/05 Approved Uses: Diagnose appendicitis Serious Side Effects: Heart failure Death Central nervous system reactions Infusion reactions Related Topics: Defective Drugs The companies said that two deaths attributed to cardiopulmonary failure, and additional cases of serious cardiopulmonary events, occurred to patients within 30 minutes of their injection with NeutroSpec. The serious cardiopulmonary events included cardiac arrest, hypoxia, dyspnea, and hypotension. The majority of the reactions occurred in patients with underlying cardiopulmonary disease who received NeutroSpec for unapproved indications. Physicans often prescribe approved medications for "off-label” use. NeutroSpec, approved for marketing in July 2004, is a diagnostic imaging agent that is administered intravenously to help diagnose appendicitis in patients five years and older with possible appendicitis who lack its conventional signs and symptoms. The FDA said the decision to suspend marketing was based on the life-threatening nature of the associated adverse events, the unpredictability of the reaction, and availability of other means of diagnosing appendicitis that do not carry these risks. If you or a loved one has been injured by NeutroSpec, Parker & Waichman, LLP will evaluate your case for free. Click here for a free, no obligation, case evaluation.